Fcγ receptors in phagocytes

Current Opinion in Hematology

Volumn 5, Issue 1, 1998, Pages 16-21

  McKenzie, Steven E ^a   Schreiber, Alan D ^b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G;

HUMAN; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 0031952299     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199801000-00003     Document Type: Review

References (65)

1. Sylvestre DL, Ravetch JV: A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 1996, 5:387-390.
2. deAndres B, Rakasz E, Hagen M, McCormik ML, Mueller AL, Elliot D, Metwali A, Sandor M, Britigan BE, Weinstock JV, et al.: Lack of Fcγ receptors on murine eosinophils: Implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997, 89:3497-3501.
3. Morton HC, van Egmond M, van de Winkel JG: Structure and function of human IgA Fc receptors (FcγR). Crit Rev Immunol 1996, 16:423-440.
4. Van de Winkel JG, Capel PJA: Human IgG Fc receptors. Heidelberg: Springer; 1996.
5. Ravetch JV: Fc receptors. Curr Opin Immunol 1997, 9:12-125.
6. Ghetie V, Popov S, Borvak J, Radu C, Matesoi D, Medesan C, Ober RJ, Ward ES: Increasing the serum persistence of an IgG fragment by random mutagenesis. Nature Biotech 1997, 15:63-640.
7. Galon J, Bouchard C, Fridman WH, Sautes C: Llgands and biological activities of soluble Fcγ receptors, Immunol Lett 1995, 44:175-181.
8. Rappaport EF, Cassel DL, Walterhouse DO, McKenzie SE, Surrey S, Keller MA, Schreiber AD, Schwartz E: A soluble form of the human Fcγ receptor, FcgRIIA: cloning, transcript analysis and detection. Exp Hematol 1993, 21:689-696.
9. Leino L, Sorvajarvi K, Katajisto J, Laine M, Lilius EM, Pelliniemi TT, Rajamaki A, Silvoniemi P, Nikoskelainen J: Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophlls in vivo. Clin Exp Immunol 1997, 107:37-43.
10. Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG: Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest 1996, 97:331-338.
11. Cassel DL, Keller MA, Surrey S, Schwartz E, Schreiber AD, Rappaport EF, McKenzie SE: Differential expression of FcgRIIA, FcgRIIB and FcgRIIC in hematopoietic cells: analysis of transcripts. Mol Immunol 1993, 30:451-460.
12. Munn DH, Bree AG, Beall AC, Kaviani MD, Sabio H, Schaub RG, Alpaugh RK, Weiner LM, Goldman SJ: Recombinant human M-CSF in nonhuman primates-selective expansion of a CD16(+) moncyte subset with phenotypic similarity to primate natural killer cells. Blood 1996, 88:1215-1224.
13. Calzada-Wack JC, Frankenberger M, Ziegler-Heitbrock HW: Interleukin-10 drives human monocytes to CD16 positive macrophages. J Inflamm 1996, 46:78-85.
14. Gessner JE, Grussenmeyer T, Dumbsky M, Schmidt RE: Separate promoters from proximal and medial control regions contribute to the natural killer cell specific transcription of the human FcγRIII-A (CD16-A) receptor gene. J Biol Chem 1996, 271:30755-30764.
15. Li M, Wirthmueller U, Ravetch JV: Reconstituion of human FcγRIII cell type specificity in transgenic mice. J Exp Med 1996, 183:1259-1263. Regulated differential expression in vivo is shown to involve multiple genomic areas.
16. Kuster H, Thompson H, Kinet JP: Characterization and expression of the gene for the human Fc receptor γ subunit J Biol Chem 1990, 265:6448-6452.
17. Worth RG, Mayo-Bond L, van de Winkel JG, Todd RF, Petty HR: CR3 (gMg2 CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective FcγRIIA (CD32) tailminus mutant J Immunol 1996, 157:5660-5665. One of several papers [18-20] showing interesting roles for receptor cross-talk and cooperation in phagocytosis.
18. Todd RF, Petty HR: g2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. J Lab Clin Med 1997, 129:492-498.
19. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγγ receptor IIIb enhances Fcγγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995, 95:2877-2885.
20. Edberg JC, Kimberly RP: Modulation of Fcγ and complement receptor function by the glycosyl-phosphatidyl inositol-anchored form of FcγRIII. J Immunol 1994, 152:5826-5835.
21. Vossebeld PH, Kessler J, von dem Borne AD, Roos D, Verhoeven AJ: Heterotypic FcγR clusters evoke a synergistic Ca2+ response in human neutrophils. J Biol Chem 1995, 270:10671-10679.
22. Reilly AF, Norris CF, Surrey S, Bruchak FJ, Rappaport EF, Schwartz E, McKenzie SE: Genetic diversity human Fc receptor II for Immunoglobulin G: Fcγ receptor IIA ligand-binding polymorphism. Clin Diag Lab Immunol 1994, 1:640-644.
23. Rascu R, Repp R, Westerdaal NA, Kalden JR, van de Winkel JG: Clinical relevance of Fcγ receptor polymorphisms. Ann N Y Aced Sci 1997, 815:282-295.
24. Norris CF, Surrey S, Bunin GR, Schwartz E, Buchanan GR, McKenzie SE: Relationship between Fc receptor IIA polymorphism and Infection in children with sickle cell disease. J Pediatr 1996, 128:813-819.
25. Hall MA, Hickman ME, Baker CJ, Edwards MS: Complement and antibody in neutrophil-mediated killing of type V group B streptococcus. J Infect Dis 1994, 170:88-93.
26. Noya FJ, Baker CJ, Edwards MS: Neutrophll Fc receptor participation in phagocytosis of type III group B streptococci. Infect Immun 1993, 61:1415-1420.
27. Sanders LA, Feldman RG, Voorhorst-Ogink MM, de Haas M, Rijkers GT, Capel PJ, Zegers BJ, van de Winkel JG: Human immunoglobulln G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995, 63:73-81.
28. Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV: Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 1996, 184:2385-2392. Critical roles for FcγR in vivo emerge in studies comparing mice that are genetically deficient in complement or Fc receptors.
29. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, et al.: Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 1996, 5:181-188. In the knockout mouse, FcγRIII is shown to possess additional broad properties in immunity.
30. Mitchell MA, Huang M-M, Indik ZK, Chien P, Pan XQ, Schreiber AD: Substitutions and deletions in the cytoplasmic domain of the phagocytic receptor FcgRIIA. Effect on receptor tyrosine phosphorylation and phagocytosis. Blood 1994, 84:1753-1759.
31. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV: FcR γ-chain deletion results in pleiotropic effector cell defects. Cell 1994, 76:519-529.
32. Clynes R, Ravetch JV: Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995, 3:21-26.
33. Vanvugt MJ, Heijnen IA, Capel PJ, Parks SY, Ra CS, Saito T, Verbeek JS, van de Winkel JG: FcR gamma-chain is essential for both surface expression and function of human FcgRI (CD64) in vivo. Blood 1996, 87:3593-3599. Transgenic mouse studies show that FcγRI relies for the most part on FcR gamma chain for expression in vivo, like FcγRIIIA. This is in contrast to the situation with FcγRI in vitro.
34. Shepard SL, Hadley AG: Monocyte-bound monoclonal antibodies Inhibit the FcγRI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen. Immunology 1997, 90:314-322.
35. de Haas M, Koene HR, Kleijer M, de Vries E, Simsek S, van Tol MJ, Roos O, von dem Some AE: A triallellc Fcγ receptor type IIIA polymorphism influences the binding of human IgG by natural killer cell FcγRIIIA. J Immunol 1996, 156:3948-3955.
36. Bux J, Stein E-L, Bierling P, Fromont P, Clay M, Stroncek D, Santoso S: Characterization of a new alloantigen (SH) on the neutrophil Fcγ receptor IIIb. Blood 1997, 89:1027-1034.
37. Norris CF, Pricop L, Millard SS, Taylor SM, Surrey S, Schwartz E, Salmon JE, McKenzie SE: A naturally occuring mutation in FcγRIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor. Blood 1998, 91:1-8.
38. Raghavan M, Bjorkman PJ: Fc receptors and their interactions with immunoglobulins. Ann Rev Cell Dev Biol 1996, 12:1B-220.
39. Goldsmith EB, Erickson BW, Thompson NL: Synthetic peptides from mouse Fc receptor (mFcγRII) that alter the binding of IgG to mFcγRII. Biochemistry 1997, 36:952-959.
40. Tamm A, Kister A, Nolte KU, Gessner JE, Schmidt RE: The IgG binding site of human FcγRIIIB receptor Involves CC' and FG loops of the membrane-proximal domain. J Biol Chem 1996, 271:3659-3666.
41. Miller KL, Duchemin AM, Anderson CL: A novel role for the Fc receptor gamma subunit: enhancement of FcγR ligand affinity. J Exp Med 1996, 183:2227-2233. FcR gamma chain enhances affinity beyond its roles in co-expression and signal transduction.
42. El Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM: syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc Natl Acad Sci U S A 1997, 94:1919-1924.
43. Taylor N, Jahn T, Smith S, Lamkin T, Uribe L, Liu Y, Durden DL, Weinberg K: Differential activation of the tyrosine kinases ZAP-70 and Syk after FcγRI stimulation. Blood 1997, 89:388-396. Macrophage-like cells preferentially use Syk in FcγRI signaling.
44. Darby C, Geahlen RL, Schreiber AD: Stimulation of macrophage FcγRIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins Including p95Vav and p62/GAP-associated protein. J Immunol 1994, 152:5429-5437.
45. Matsuda M, Park JG, Wang DC, Hunter S, Chien P, Schreiber AD: Abrogation of the FcγRIIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides. Mol Biol Cell 1996, 7:1095-1106. Phagocytosis is critically dependent on the presence of Syk kinase.
46. Indik ZK, Park JG, Hunter S, Schreiber AD: The molecular dissection of Fcγ receptor mediated phagocytosis. Blood 1995, 86:4389-4399.
47. Indik ZK, Park JG, Pan XQ, Schreiber AD: Induction of phagocytosis by a protein tyrosine kinase. Blood 1995, 85:1175-1180.
48. Park JG, Schreiber AD: Determinants of the phagocytic signal mediated by the type IIIA Fcγ receptor, FcγRIIIA: sequence requirements and interaction with protein-tyrosine kinases. Proc Natl Acad Sci U S A 1995, 92:7381-7385.
49. Indik ZK, Hunter S, Huang MM, Pan XQ, Chien P, Kelly C, Levinson AI, Kimberly RP, Schreiber AD: The high affinity Fcγ receptor (CD64) induces phagocytosis in the absence of its cytoplasmic domain: the gamma subunit of FcγRIIIA imparts phagocytic function for FcgRI. Exp Hematol 1994, 22:599-606.
50. Chacko GW, Brandt JT, Coggeshall KM, Anderson CL: Phosphoinositide 3-kinase and p72syk noncovalently associate with the low affinity Fc gamma receptor on human platelets through an immunoreceptor tyrosine-based activation motif. Reconstitution with synthetic phosphopeptides. J Biol Chem 1996, 271:10775-10781.
51. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 1996, 379:346-349.
52. Kiener PA, Lioubin MN, Rohrschneider LR, Ledbetter JA, Nadler SG, Diegel ML: Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphtidylinositol 3-kinase and inositol 5'-phosphatase with the antigen receptor complex. J Biol Chem 1997, 272:3838-3844.
53. Hunter S, Indik ZK, Kim MK, Park JG, Schreiber AD: Activation of the Fcg receptor FcγRIIB negatively regulates phagocytosis by the Fcγ receptor FcγRIIA. Blood 1998, in press.
54. Gewirtz AT, Simons ER: Phospholipase D mediates Fcγ receptor activation of neutrophils and provides specificity between high-valency Immune complexes and fMLP signaling pathways. J Leukoc Biol 1997, 61:522-528.
55. Floto RA, Somasundaram B, Allen JM, Mahaut-Smith MP: Fcg receptor I activates a novel Ca2+-activated current selective for monovalent cations in the human monocytic cell line, U937. J Biol Chem 1997, 272:4753-4758.
56. Tapper H, Grinstein S: Fc receptor-triggered insertion of secretory granules Into the plasma membrane of human neutrophils: selective retrieval during phagocytosis. J Immunol 1997, 159:409-418.
57. Cox D, Chang P, Kurosaki T, Greenberg S: Syk tyrosine kinase is required for Immunoreceptor tyrosine activation motif-dependent actin asembly. J Biol Chem 1996, 271:16597-16602.
58. Rose DL, Winston BW, Chan ED, Riches DW, Gerwins P, Johnson GL, Henson PM: Fcγ receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role of p42MAPK in Fcg receptor-stimulated TNF-γ synthesis. J Immunol 1997, 158:3433-3438.
59. Park RK, Liu Y, Durden DL: A role for Shc, Grb2 and Raf-1 in FcγRI signal relay. J Biol Chem 1996, 271:13342-13348. Key intracellular players in FcγR signal transduction beyond PTKs are identified.
60. Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV: Organization of the human and mouse low affinity FcγRII genes: duplication and recombination. Science 1990, 248:732-737.
61. Warmerdam PA, Nabben NM, van de Graef SA, van de Winkel JG, Capel PJ: The human low affinity lmmunoglobulln G Fc receptor IIC gene is a result of an unequal crossover event J Biol Chem 1993, 268:7346-7349.
62. McKenzie SE, Keller MA, Cassel DL, Schreiber AD, Schwartz E, Surrey S, Rappaport EF: Characterization of the 5'-flanking transcriptional regulatory region of the human Fcγ receptor gene, FcγRIIA. Mol Immunol 1992, 29:1165-1174.
63. Hughes AL: Gene duplication and recombination in the evolution of mammalian Fc receptors. J Mol Evol 1996, 43:4-10.
64. Reilly AF, Surrey S, Rappaport EF, Schwartz E, McKenzie SE: Variation in human FCGR2C gene copy number, Immunogenetics 1994, 40:456.
65. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne EA: Neutrophil FCγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995, 86:2403-2413.